Linnaeus Therapeutics announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of...
Read moreHeart valve innovator Foldax®, a company reinventing every aspect of the heart valve, from material to design to manufacturing,...
Read moreFor the past few years in Torrance, California, Transient Plasma Systems (TPS) quietly has been developing an aftertreatment emissions...
Read moreLinnaeus Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for LNS8801 for...
Read moremmWave 5G networks have great potential and are needed to provide capacity beyond the existing LTE and sub-6 GHz...
Read moreLinnaeus Therapeutics, Inc. announced that its scientific co-founders, Christopher Natale, PhD, Vice President of Research at Linnaeus and Todd...
Read moreTanvasTouch surface haptic technology has received the 2020 Display Component of the Year award from the Society for Information...
Read moreFoldax Tria™ LifePolymer™ heart valve technology wins “Medical Device Engineering Breakthrough Award” in the fourth annual MedTech Breakthrough Awards...
Read moreMemVerge™, the inventor of Memory Machine™ software, today announced the company was named a Gold Stevie® Award winner in...
Read moreWe are thrilled to announce our investment in FGC Plasma Solutions, founded in 2013 to commercialize research into plasma-assisted...
Read more